In this study, we revealed the precise mechanism by which TOP2 poisons induce TOP2β degradation and demonstrated that specifically blocking TOP2β degradation remarkably sensitizes cancer cells to VM-26 treatment (Fig. 7). The gene discussed is TOP2A; the disease is cancer.